Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions

The advent of immunotherapy has revolutionized cancer treatment. Unfortunately, this has not been the case for metastatic castration-resistant prostate cancer (mCRPC), likely due to the heterogeneous and immune-suppressive microenvironment present in prostate cancer. The identification of molecular...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Fernando López-Campos, Pablo Gajate, Nuria Romero-Laorden, Juan Zafra-Martín, Manel Juan, Susana Hernando Polo, Antonio Conde Moreno, Felipe Couñago
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-02-01
Edice:	Biomedicines
Témata:	immunotherapy metastatic castration-resistant prostate cancer advanced prostate cancer cancer vaccines immune checkpoints inhibitors
On-line přístup:	https://www.mdpi.com/2227-9059/10/3/537
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!